Participate in a live streaming video episode of This Week in Virology (TWiV), a podcast about viruses. Started in September 2008 by Vincent Racaniello, a Higgins Professor in the Department of Microbiology and Immunology at Columbia University, the goal of the show is to have an accessible discussion about viruses that anyone can understand and enjoy. In Washington, D.C., Racaniello, co-host Condit, and guests Kawaoka and Hruby will discuss antivirals against smallpox and influenza viruses H5N1 and H7N9. Audience participation is encouraged. Please feel free to ask any questions or offer your comments up to discussion.
Vincent Racaniello; Columbia Univ. Coll. of Physicians & Surgeons, NY
Richard C. Condit; Univ. of Florida, Gainesville, FL
Yoshihiro Kawaoka; Dept. of Pathobiological Sc., Univ. of Wisconsin, Madison, Madison, WI
Dennis Hruby; SIGA Technologies, Inc., Corvallis, OR
Your DD is greatly appreciated with these last 2 posts. Most companies have either an in house PR rep. or an
outfit that is contracted to report things like the nature of your 2 last posts. Patents, conferences, scientific symposiums,amount of Arvestyr delivered, money collected,- it's a shame that a message board has to be the source of these types of information with a very limited audience rather than a news release. It seems as though SIGA wants to avoid any type of attention to lessen its own value because of this darn lawsuit. Investors meanwhile have to suffer and wait.
Which, if true, is ABSOLUTELY moronic because (1), clearly any schmo can google these things on the internet and (2), what does SIGA's other drug pipeline have ANYTHING to do with the lawsuit? Only a moronic management team with an imbicile for a CEO would think Parson would change his award based on how well the company is doing with it's OTHER drugs! I've never heard of anything so stupid in my life. So, as to having hope that our CEO et al are not REALLY that stupid....it basically goes back to the fact that they don't care about the share price or promoting their company....thus they don't care about the little shareholder. Heck, if they need money, all they have to do is issue themselves more shares and turn around and sell them to suckers like us.